Provided by Tiger Trade Technology Pte. Ltd.

NLS Pharmaceutics Ltd. Warrant

0.0179
0.0000
Volume:- -
Turnover:- -
Market Cap:65.09K
PE:-0.01
High:0.0179
Open:0.0179
Low:0.0179
Close:0.0179
52wk High:0.0400
52wk Low:0.0009
Shares:3.64M
Float Shares:3.64M
Volume Ratio:1.51
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0387
ROE:-862.92%
ROA:-75.98%
PB:0.02
PE(LYR):- -

Loading ...

Company Profile

Company Name:
NLS Pharmaceutics Ltd. Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.